1
Home
Companies

Yield10 Bioscience

#10000

Rank

$539.29K

Marketcap

US United States

Country

Yield10 Bioscience
Leadership team

Dr. Kristi D. Snell (VP of Research & Chief Science Officer)

Dr. Oliver P. Peoples (Co-Founder, Pres, CEO & Director)

Dr. Anthony J. Sinskey Ph.D., Sc.D. (Co-Founder & Independent Director)

Products/ Services
Biotechnology, Chemical, Energy
Headquarters
Woburn, Massachusetts, United States
Established
2015
Company Registration
SEC CIK number: 0001121702
Revenue
500K - 2M
Traded as
YTEN
Social Media
URL
https://www.yield10bio.com
Overview
Location

Summary
History
Mission
Vision
Key Team
Recognition and Award
References
Summary
Yield10 Bioscience, Inc., an agricultural bioscience company, engages in developing technologies to enable step-change increases in crop yield in the United States and Canada. The company, through its Trait Factory, a trait gene discovery platform develops enhanced oilseed Camelina sativa for the production of proprietary seed products; and discovers high value genetic traits for the agriculture and food industries. Yield10 Bioscience, Inc. has license agreements with GDM Seeds; J. R. Simplot; Forage Genetics International, LLC; and Bayer AG. The company was formerly known as Metabolix, Inc. and changed its name to Yield10 Bioscience, Inc. in January 2017. Yield10 Bioscience, Inc. was incorporate in 1992 and is headquartered in Woburn, Massachusetts.
History

Founded in 1992, with the help of a licensing agreement with Massachusetts Institute of Technology , Metabolix, Inc. is a bioscience company with headquarters in Cambridge, Massachusetts. Metabolix provides sustainable solutions to the plastic, chemical and energy industries. Oliver Peoples, Ph.D., and Anthony Sinskey, Ph.D., co-founded Metabolix after work at the that identified the elementary methods and means for engineering polyhydroxyalkanoates production in plants and bacteria, thus making them biodegradable.In early 2017, Metabolix became Yield10 Bioscience, its crop research program.

Mission
Yield10 Bioscience is focused on enabling a secure and reliable global food supply by using genetic approaches to develop crop yield and address key agricultural threats.
Vision
At Yield10 Biosicence, our vision is to revolutionize crop yield by creating innovative scientific solutions that drive performance, profitability and sustainability to the global food supply.
Key Team

Ms. Lynne H. Brum (VP of Planning & Corp. Communications and Sec.)

Dr. Nicholas Renegar Ph.D. (Director of Bus. Analytics & Operations)

Mr. Charles B. Haaser (VP of Fin., Chief Accounting Officer & Treasurer)

Recognition and Awards
Yield10's renewable energy technology was recognized with the 2017 BioEnergy Insight Award for best Industrial Investment in Renewable Energy.
References

https://en.wikipedia.org/wiki/Yield10_Bioscience

https://in.investing.com/equities/metabolix-inc

https://finance.yahoo.com/quote/YTEN/profile?p=YTEN

https://www.crunchbase.com/organization/metabolix

https://companiesmarketcap.com/

https://www.yield10bio.com

Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

Yield10 Bioscience
Leadership team

Dr. Kristi D. Snell (VP of Research & Chief Science Officer)

Dr. Oliver P. Peoples (Co-Founder, Pres, CEO & Director)

Dr. Anthony J. Sinskey Ph.D., Sc.D. (Co-Founder & Independent Director)

Products/ Services
Biotechnology, Chemical, Energy
Headquarters
Woburn, Massachusetts, United States
Established
2015
Company Registration
SEC CIK number: 0001121702
Revenue
500K - 2M
Traded as
YTEN
Social Media
URL
https://www.yield10bio.com